We found that DSF/Cu up-regulated the expression of CXCL10, CCL5 and IFN-β in multiple high metastatic breast cancer cell lines, which was associated with the activation of the STING-TBK1-IRF3 pathway. Here, IRF3 is linked to breast carcinoma.